Recent Finacing
Recent Raise
Spark Therapeutics develops one-time gene therapies for rare inherited retinal and hematological diseases and operates a proprietary manufacturing platform supporting clinical and preclinical gene therapy programs across administration routes.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors